COMPOSITION FOR PLASMA AND SERUM SEPARATION, AND CONTAINER FOR BLOOD TESTING
    8.
    发明申请
    COMPOSITION FOR PLASMA AND SERUM SEPARATION, AND CONTAINER FOR BLOOD TESTING 有权
    用于血浆和血清分离的组合物和用于血液测试的容器

    公开(公告)号:US20120070350A1

    公开(公告)日:2012-03-22

    申请号:US13320782

    申请日:2011-01-25

    IPC分类号: B01L3/00 B03D1/018

    摘要: The invention provides a serum or plasma separating composition which can compensate for the lack of initial thixotropy even at a reduced inorganic powder concentration and in which crevices or the like are less likely to be created in a partition wall formed of the separating composition after being centrifuged. The serum or plasma separating composition contains a liquid resin component having a partition wall-forming capability, a hydrophilic inorganic powder, a hydrophobic inorganic powder, and an organic compound serving as a thixotropy enhancer, wherein the organic compound is a polyalkylene glycol and/or a derivative thereof and is made of at least one type of polymer selected from the group consisting of: 1) a homopolymer of a single type of monomer selected from C3 to C5 alkylene oxide monomers; 2) a random copolymer, an altering copolymer, or a periodic copolymer of two or more types of monomers selected from C2 to C5 alkylene oxide monomers; 3) a block copolymer of two or more types of monomers selected from C3 to C5 alkylene oxide monomers; and 4) a graft copolymer of at least one type of polymer selected from the polymers 1) to 3), the polyalkylene glycol and/or the derivative thereof has a number average molecular weight of 500 to 100000, both inclusive, and the content of the polyalkylene glycol and/or the derivative thereof in the total amount of the serum or plasma separating composition is 0.2% to 5% by weight, both inclusive.

    摘要翻译: 本发明提供血清或血浆分离组合物,其即使在降低的无机粉末浓度下也可补偿初始触变性的缺乏,并且在离心后在分离组合物形成的分隔壁中不太可能产生裂缝等 。 血清或血浆分离组合物含有具有分隔壁形成能力的液体树脂组分,亲水性无机粉末,疏水性无机粉末和用作触变增强剂的有机化合物,其中有机化合物是聚亚烷基二醇和/或 其衍生物由至少一种选自以下的聚合物制成:1)选自C3至C5烯化氧单体的单一类型的单体的均聚物; 2)选自C2至C5烯化氧单体的两种或多种类型单体的无规共聚物,改变共聚物或周期共聚物; 3)选自C3至C5环氧烷单体的两种或更多种类型的单体的嵌段共聚物; 和4)选自聚合物1)至3)中的至少一种类型的聚合物的接枝共聚物,所述聚亚烷基二醇和/或其衍生物的数均分子量为500〜100000,其含量为 血清或血浆分离组合物的总量中的聚亚烷基二醇和/或其衍生物的含量为0.2重量%〜5重量%。